Inorganic mesoporous silicas as vehicles of two novel anthracene-based ruthenium metalloarenes

Novel trackable ruthenium metallodrugs have been evaluated against biorelevant molecules and leukemia cancer cells as well as encapsulated into mesoporous silica matrixes.200